Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period

NCT ID: NCT07302295

Last Updated: 2025-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

6500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-31

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.

Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).

Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.

The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicidality COVID -19

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

suicide pediatrics covid-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Multicenter descriptive study, involving retrospective data collection with a questionnaire and prospective qualitative evaluations. Research involving human subjects outside of health products as mentioned in Article L1121-1, 2° of the Public Health Code
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1)

* Name : Group 1
* Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022.
* Age ≥ 8 years old and \< 18 years old between 2020 and 2022.

Group Type EXPERIMENTAL

Aggregated data collection

Intervention Type OTHER

The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.

Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b)

* Name : Group 1b
* Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents
* Age ≥ 8 years old and \< 18 years old between 2020 and 2022 for subjects.
* One or both parents
* Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects).
* Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.

Group Type EXPERIMENTAL

Data collection and qualitative interview

Intervention Type OTHER

The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.

Subjects control with suicidal behaviors before the health crisis (Group 2).

* Name: group 2
* Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region
* Age ≥ 8 years old and \< 18 years old between 2018 and 2019

Group Type EXPERIMENTAL

Aggregated data collection

Intervention Type OTHER

The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aggregated data collection

The demographic and diagnostic characteristics will be collected in aggregate form nafrom digital services departments or medical information departments of participating hospitals.

Intervention Type OTHER

Data collection and qualitative interview

The psychopathological and socioeconomic characteristics will be collected. For subjects who agreed, they will participate in interviews and/or focus groups. Parent's subjects who agreed will be part of focus groups too.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The population (subjects and controls) will be divided into age categories:

* Pre-adolescents (≥ 8 years and \< 11 years)
* Adolescents (≥ 11 years and \< 15 years)
* Older adolescents (≥ 15 years and \< 18 years)

Subjects with suicidal behavior during the health crisis (Group 1):

* Age \> 8 years and \< 18 years during the period 2020 to 2022.
* Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):

* Age \> 8 years and \< 18 years during the period 2020 to 2022.
* Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
* Randomly selected from the population of Group 1.
* For whom the parent(s) and/or the subject have signed informed consent.

Controls with suicidal behavior before the health crisis (Group 2):

* Age \> 8 years and \< 18 years during the period 2018 to 2019.
* Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

Exclusion Criteria

\- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):

• Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.

Controls with Suicidal Behavior before the Health Crisis (Group 2):

* Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
* Intercurrent illness with a life expectancy of less than 24 hours.

For Group 1:

* Pregnant, postpartum, or breastfeeding women.
* Persons deprived of liberty by judicial or administrative decision.
* Adults subject to a legal protection measure (guardianship, curatorship).
* Persons not affiliated with a social security scheme or beneficiaries of a similar scheme.
* Persons who do not understand and do not speak French.
Minimum Eligible Age

8 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospices Civils de Lyon - Hôpital Femme Mère Enfant- Service de pédopsychiatrie de l'enfant et de l'adolescent

Bron, , France

Site Status

CHU de Clermont-Ferrand - Service de psychiatrie de l'enfant et de l'adolescent

Clermont-Ferrand, , France

Site Status

CHU de Grenoble - Service de psychiatrie de l'enfant et de l'adolescent

Grenoble, , France

Site Status

CHU de Saint-Etienne - Urgences psychiatriques

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elise MAMIMOUE, Dr

Role: CONTACT

Phone: 472129567

Email: [email protected]

Sonia GALLETTI

Role: CONTACT

Phone: 427857739

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elise MAMIMOUE, Dr

Role: primary

Jonathan Lachal, Pr

Role: primary

Stéphanie Bioulac, Dr

Role: primary

Catherine Massoubre, Pr

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A02237-38

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL22_1175

Identifier Type: -

Identifier Source: org_study_id